Un-audited financial results along with limited review report for the quarter ended 30.06.2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gayatri BioOrganics reported its unaudited financial results for the quarter ended 30 June 2025 at a board meeting held on 29 July 2025. The results show losses, with a cumulative loss figure of around ₹3,589 lakhs visible in the filings, and an Exceptional Items line has been recorded in the P&L. The auditor (MGR & Co, Hyderabad) issued an unmodified limited review report with no qualifications. Importantly, the company prepared its books on a 'going concern' basis relying on a comfort letter from promoters for continued support. The board also approved the 34th Directors' Report and fixed the 34th AGM on 26 August 2025 via video conferencing.
Shareholders should note the company is loss-making and is relying on promoter support to continue as a going concern, which is a key risk factor even though the auditor raised no concerns. The AGM on 26 August will be the next opportunity for investors to seek clarity on the path to profitability.